Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing … Read more
Advanced Enzyme Technologies Limited (ADVENZYMES) - Total Liabilities
Latest total liabilities as of September 2025: ₹1.58 Billion INR
Based on the latest financial reports, Advanced Enzyme Technologies Limited (ADVENZYMES) has total liabilities worth ₹1.58 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Advanced Enzyme Technologies Limited - Total Liabilities Trend (2008–2025)
This chart illustrates how Advanced Enzyme Technologies Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Advanced Enzyme Technologies Limited Competitors by Total Liabilities
The table below lists competitors of Advanced Enzyme Technologies Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hemisphere Energy Corporation
OTCQX:HMENF
|
USA | $43.80 Million |
|
Burcelik Vana Sanayi ve Ticaret AS
IS:BURVA
|
Turkey | TL11.43 Million |
|
Bonny Worldwide Ltd
TW:8467
|
Taiwan | NT$1.73 Billion |
|
Norsyn Crop Technology Co. Ltd. A
SHE:001231
|
China | CN¥460.85 Million |
|
Count Ltd
AU:CUP
|
Australia | AU$322.99 Million |
|
Cikarang Listrindo Tbk PT
JK:POWR
|
Indonesia | Rp487.44 Million |
|
CALTAGIRONE EDITORE (EDJ.SG)
STU:EDJ
|
Germany | €109.51 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Advanced Enzyme Technologies Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.72 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Advanced Enzyme Technologies Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Advanced Enzyme Technologies Limited (2008–2025)
The table below shows the annual total liabilities of Advanced Enzyme Technologies Limited from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹1.53 Billion | -7.12% |
| 2024-03-31 | ₹1.64 Billion | +19.40% |
| 2023-03-31 | ₹1.38 Billion | +8.22% |
| 2022-03-31 | ₹1.27 Billion | +4.36% |
| 2021-03-31 | ₹1.22 Billion | +9.67% |
| 2020-03-31 | ₹1.11 Billion | +4.58% |
| 2019-03-31 | ₹1.06 Billion | -29.13% |
| 2018-03-31 | ₹1.50 Billion | +44.13% |
| 2017-03-31 | ₹1.04 Billion | -37.73% |
| 2016-03-31 | ₹1.67 Billion | -16.24% |
| 2015-03-31 | ₹1.99 Billion | -15.12% |
| 2014-03-31 | ₹2.35 Billion | +2.14% |
| 2013-03-31 | ₹2.30 Billion | -8.30% |
| 2012-03-31 | ₹2.51 Billion | +180.57% |
| 2011-03-31 | ₹894.39 Million | +48.72% |
| 2010-03-31 | ₹601.38 Million | +7.27% |
| 2009-03-31 | ₹560.60 Million | -4.56% |
| 2008-03-31 | ₹587.36 Million | -- |